Story

RBC Downgrades Amrize to 'Underperform' on Margin Pressure and Cost Headwinds

ENTHMSVIIDZHZH-TWJAKOHI
Aug 10, 20262 min read
RBC Downgrades Amrize to 'Underperform' on Margin Pressure and Cost Headwinds
Text size
Background

RBC Capital Markets downgraded building materials producer Amrize Ltd. to “underperform” from “sector perform” and slashed its price target to $48 from $60. The revision follows the company's second-quarter earnings, where significant cost inflation eroded profit margins despite higher-than-expected revenue.

Second-Quarter Miss Drives Downgrade

Amrize reported second-quarter revenue of $3.49 billion, beating the consensus estimate of $3.36 billion, driven by a 6.7% increase in organic growth. However, its quarterly EBITDA of $986 million fell 2.1% short of the $1.01 billion consensus forecast.

The miss was attributed to a significant squeeze on profitability. The company’s EBITDA margin fell to 28.2%, which was 173 basis points below consensus and 74 basis points lower than the same period last year. RBC noted that Amrize was the only major "heavyside" building materials company to miss Q2 consensus and lower its full-year guidance, while peers like CRH and Vulcan Materials beat estimates and maintained their outlooks.

Cost Inflation Overwhelms Savings

RBC's analysis pointed to a substantial gap between rising costs and the company's savings initiatives. Key factors highlighted in the broker's note include:

Sample IUX Markets – In-articleAd
  • A $75 million headwind from oil-driven cost inflation affecting freight, diesel, and raw materials.
  • Only $29 million in offsetting savings from Amrize’s ASPIRE cost-savings program, resulting in a net negative impact of about $46 million.
  • A $78 million understatement of deferred revenue related to recent acquisitions, which required revisions to prior financial statements, though Amrize deemed the issue "not material."

Following the results, RBC cut its full-year 2026, 2027, and 2028 EBITDA estimates for Amrize by 3.8%, 6.3%, and 7.3%, respectively. The broker is now modeling toward the lower end of the company's revised annual guidance of $3.1-$3.2 billion.

Revised Valuation and Outlook

The new $48 price target is based on a lower valuation multiple, with RBC cutting its target EV/EBITDA multiple for Amrize to 9.5x from a previous 11.5x. The broker noted that while Amrize's current valuation is in line with competitor CRH, it lacks CRH's consistent 12-year track record of margin expansion.

RBC stated it would reassess its bearish rating if Amrize can deliver positive price-to-cost trends for two consecutive quarters, achieve sustained quarterly savings of over $50 million from its ASPIRE program, or see year-over-year cement pricing turn positive for two straight quarters.

Read next

More on Stocks
Back to latest news

LATEST